Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/bf00311501.

Title:
Skip metastasis and hidden N2 disease in lung cancer: How successful is mediastinal dissection? | Surgery Today
Description:
Out of 703 consecutive patients who underwent lung cancer surgery from 1986 to 1994, 562 were studied with an emphasis on lymph node metastasis. Skip metastasis was defined as metastasis to the upper mediastinum without involvement of the carinal, hilar, or intrapulmonary nodes. Twenty-nine patients had skip metastasis, accounting for 17% of the 175 with N2 disease. Except for one patient with a huge tumor, there was no lower-lobe disease. Patients with N2 disease nodes were categorized into the following groups: (1) 32 with false negative N2 that could not be detected macroscopically on the specimen; (2) 64 with true positive N2, detected macroscopically on the specimen; and (3) 79 patients with obvious N2. Positive carinal nodes were found in 12 of 70 N2 patients who underwent upper lobectomy, and in 60 of the (105) remaining N2 patients who had other types of surgery. We conclude that upper mediastinal disection should be carried out in patients with adenocarcinoma in the upper lobe, because skip and undetectable metastasis are not rare. However, dissection of the carinal nodes with upper-lobe tumors, and of the upper mediastinum with lower-lobe tumors, can be omitted when the gross and frozen section findings are negative in the upper mediastinum and both the carinal and hilar nodes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Health & Fitness
  • Science
  • Cryptocurrency

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We're unsure if the website is profiting.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {πŸ”}

lung, metastasis, cancer, article, patients, skip, mediastinal, lymph, nodes, google, scholar, node, upper, access, surg, privacy, cookies, content, surgery, disease, publish, search, dissection, mediastinum, carinal, carcinoma, data, information, log, journal, research, today, tsubota, yoshimura, positive, open, cell, discover, thorac, download, springer, site, optional, analysis, personal, parties, policy, find, track, hidden,

Topics {βœ’οΈ}

month download article/chapter lymph node metastasis lymph node cancer small cell carcinoma related subjects full article pdf privacy choices/manage cookies article tsubota oat cell carcinoma hidden n2 disease n2 disease nodes skip metastasis upper mediastinal disection true positive n2 lower-lobe disease lung cancer european economic area frozen section findings mediastinal dissection check access instant access lower-lobe tumors conditions privacy policy original articles published underwent upper lobectomy positive carinal nodes upper-lobe tumors accepting optional cookies false negative n2 usage analysis main content log remaining n2 patients surg today 26 undetectable metastasis mediastinal metastases journal finder publish resectable cancer cookies skip article log n2 disease article cite privacy policy yoshimura personal data books a metastasis upper lobe optional cookies obvious n2 manage preferences

Questions {❓}

  • Skip metastasis and hidden N2 disease in lung cancer: How successful is mediastinal dissection?
  • Skip metastasis and hidden N2 disease in lung cancer: How successful is mediastinal dissection?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Skip metastasis and hidden N2 disease in lung cancer: How successful is mediastinal dissection?
         description:Out of 703 consecutive patients who underwent lung cancer surgery from 1986 to 1994, 562 were studied with an emphasis on lymph node metastasis. Skip metastasis was defined as metastasis to the upper mediastinum without involvement of the carinal, hilar, or intrapulmonary nodes. Twenty-nine patients had skip metastasis, accounting for 17% of the 175 with N2 disease. Except for one patient with a huge tumor, there was no lower-lobe disease. Patients with N2 disease nodes were categorized into the following groups: (1) 32 with false negative N2 that could not be detected macroscopically on the specimen; (2) 64 with true positive N2, detected macroscopically on the specimen; and (3) 79 patients with obvious N2. Positive carinal nodes were found in 12 of 70 N2 patients who underwent upper lobectomy, and in 60 of the (105) remaining N2 patients who had other types of surgery. We conclude that upper mediastinal disection should be carried out in patients with adenocarcinoma in the upper lobe, because skip and undetectable metastasis are not rare. However, dissection of the carinal nodes with upper-lobe tumors, and of the upper mediastinum with lower-lobe tumors, can be omitted when the gross and frozen section findings are negative in the upper mediastinum and both the carinal and hilar nodes.
         datePublished:
         dateModified:
         pageStart:169
         pageEnd:172
         sameAs:https://doi.org/10.1007/BF00311501
         keywords:
            lung cancer
            skip metastasis
            mediastinal dissection
            lymph node metastasis
            Surgery
            Surgical Oncology
         image:
         isPartOf:
            name:Surgery Today
            issn:
               1436-2813
               0941-1291
            volumeNumber:26
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Noriaki Tsubota
               affiliation:
                     name:Hyogo Medical Center
                     address:
                        name:Hyogo Medical Center, Akashi City, Hyogo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masahiro Yoshimura
               affiliation:
                     name:Hyogo Medical Center
                     address:
                        name:Hyogo Medical Center, Akashi City, Hyogo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Skip metastasis and hidden N2 disease in lung cancer: How successful is mediastinal dissection?
      description:Out of 703 consecutive patients who underwent lung cancer surgery from 1986 to 1994, 562 were studied with an emphasis on lymph node metastasis. Skip metastasis was defined as metastasis to the upper mediastinum without involvement of the carinal, hilar, or intrapulmonary nodes. Twenty-nine patients had skip metastasis, accounting for 17% of the 175 with N2 disease. Except for one patient with a huge tumor, there was no lower-lobe disease. Patients with N2 disease nodes were categorized into the following groups: (1) 32 with false negative N2 that could not be detected macroscopically on the specimen; (2) 64 with true positive N2, detected macroscopically on the specimen; and (3) 79 patients with obvious N2. Positive carinal nodes were found in 12 of 70 N2 patients who underwent upper lobectomy, and in 60 of the (105) remaining N2 patients who had other types of surgery. We conclude that upper mediastinal disection should be carried out in patients with adenocarcinoma in the upper lobe, because skip and undetectable metastasis are not rare. However, dissection of the carinal nodes with upper-lobe tumors, and of the upper mediastinum with lower-lobe tumors, can be omitted when the gross and frozen section findings are negative in the upper mediastinum and both the carinal and hilar nodes.
      datePublished:
      dateModified:
      pageStart:169
      pageEnd:172
      sameAs:https://doi.org/10.1007/BF00311501
      keywords:
         lung cancer
         skip metastasis
         mediastinal dissection
         lymph node metastasis
         Surgery
         Surgical Oncology
      image:
      isPartOf:
         name:Surgery Today
         issn:
            1436-2813
            0941-1291
         volumeNumber:26
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Noriaki Tsubota
            affiliation:
                  name:Hyogo Medical Center
                  address:
                     name:Hyogo Medical Center, Akashi City, Hyogo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masahiro Yoshimura
            affiliation:
                  name:Hyogo Medical Center
                  address:
                     name:Hyogo Medical Center, Akashi City, Hyogo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Surgery Today
      issn:
         1436-2813
         0941-1291
      volumeNumber:26
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hyogo Medical Center
      address:
         name:Hyogo Medical Center, Akashi City, Hyogo, Japan
         type:PostalAddress
      name:Hyogo Medical Center
      address:
         name:Hyogo Medical Center, Akashi City, Hyogo, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Noriaki Tsubota
      affiliation:
            name:Hyogo Medical Center
            address:
               name:Hyogo Medical Center, Akashi City, Hyogo, Japan
               type:PostalAddress
            type:Organization
      name:Masahiro Yoshimura
      affiliation:
            name:Hyogo Medical Center
            address:
               name:Hyogo Medical Center, Akashi City, Hyogo, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Hyogo Medical Center, Akashi City, Hyogo, Japan
      name:Hyogo Medical Center, Akashi City, Hyogo, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(35)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.17s.